TMCnet News
Lionbridge Life Sciences Introduces New Features of its Clinical Labeling Solution to Accelerate Global Clinical TrialsWALTHAM, Mass., June 19, 2017 /PRNewswire/ -- Lionbridge Technologies, Inc., the world's most trusted translation and digital communications company, today announced enhancements to its Clinical Labeling translation solution, an end-to-end offering that helps global life sciences organizations easily translate labeling content for clinical studies while remaining compliant with global regulatory requirements. The features of the Clinical Labeling solution include an enhanced, fully customizable workflow for label text creation, translation and validation across more than 100 markets and languages. In addition, Lionbridge Life Sciences has integrated its labeling translation solution with leading suppliers of clinical labeling design, production and management services, allowing easy integration of translation processes within clients' existing labeling management platforms. "As a global leader in clinical supply chain solutions, we needed a partner that could deliver accurate clinical labels while integrating regulatory compliance, packaging capabilities and country validation," said Jamie Pieron, Manager of Client Services Operations, Clintrak Clinical Labeling Services. "By leveraging Lionbridge's expansive global regulatory network and expertise, we can continue to provide our clients with a clinical labeling model that improves efficiency and reduces overall risk." Lionbridge's proven technology platform, combined with Lionbridge's expansive network of qualified translators and regulatory experts enables pharmaceutical and biotechnology organizations to reduce the overall label cycle times and simplify global label creation. Key benefits of the enhanced Lionbridge Clinical Labeling solution include:
"As clinical study sites increasingly expand to more and more global regions, it's imperative that organizations are fully aware of shifting regulatory requirements, or they risk errors and inconsistencies that can result in serious implications for patient safety and regulatory approval," said Mark Aiello, General Manager Lionbridge Life Sciences. "Our Clinical Labeling solution provides a simplified and customizable workflow that allows organizations to efficiently translate content and streamline their clinical labeling processes." Lionbridge's Clinical Labeling solution addresses current business challenges by utilizing a wide network of experienced experts that cover all relevant regions and health authorities for study sites. As a result, organizations can ensure that clinical labels depict the correct dosage, administration and storage instructions while remaining compliant with local and regional regulatory rules. To learn more, visit http://lifesciences.lionbridge.com/what-we-do/services-function/regulatory/. About Lionbridge Media Contact: To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lionbridge-life-sciences-introduces-new-features-of-its-clinical-labeling-solution-to-accelerate-global-clinical-trials-300475839.html SOURCE Lionbridge Technologies, Inc. |